All About Multiple Sclerosis

More MS news articles for November 2002

Arthritis during interferon beta-1b treatment in multiple sclerosis

http://www.ingenta.com/isis/searching/ExpandTOC/ingenta?issue=infobike://arn/ms/2002/00000008/00000006&index=18

Multiple Sclerosis, 1 October 2002, vol. 8, no. 6, pp. 534-536(3)
Altintas A.[1]; Alici Y.[1]; Melikoglu M.[2]; Siva A.[1]
[1] Department of Neurology, Cerrahpasa School of Medicine, 34300 Istanbul, Turkey [2] Department of Rheumatology, Cerrahpasa School of Medicine, 34300 Istanbul, Turkey
 
Interferon beta (IFN-b) is the most widely prescribed disease-modifying drug for multiple sclerosis (MS).

Therapy with IFN-b may be associated with a number of adverse reactions.

The development or exacerbation of other autoimmune diseases is a rare but reported side effect of IFN-b therapy.

In this case report, we present clinical and laboratory findings of two MS patients who developed arthritis during IFN-b1b treatment, probably of autoimmune origin.